Prognosis and prognostic factors in patients with idiopathic dilated cardiomyopathy in Japan - Results from a nationwide study

Circulation Journal

Volumn 72, Issue 3, 2008, Pages 343-348

  Miura, Katsuyuki ^a   Matsumori, Akira ^b   Nasermoaddeli, Ali ^a   Soyama, Yoshiyuki ^a   Morikawa, Yuko ^a   Sakurai, Masaru ^a   Kitabatake, Akira ^c   Nagai, Masaki ^d   Inaba, Yutaka ^e   Nakagawa, Hideaki ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathy; Epidemiology; Prognosis

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PREDICTOR VARIABLE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; SCORING SYSTEM; SEX; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, DILATED; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HEART VENTRICLES; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; STROKE VOLUME; SURVIVAL RATE;

EID: 42649104788     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.343     Document Type: Article

References (18)

1. Fuster V, Gersh BJ, Guiliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-531.
2. Diaz RA, Obasohan A, Oakley CM. Prediction of outcome in dilated cardiomyopathy. Br Heart J 1987; 58: 393-399.
3. Kawai C, Sakurai T, Kishimoto C, Tomioka N. A follow up survey for the prognosisi of idiopathic cardiomyopathies in Japan. In: Annual Report of the Research Committee on Idiopathic Cardiomyopathy, the Ministry of Health and Welfare, Japan. Tokyo: The Ministry; 1983; 63-66 (in Japanese).
4. Ikram H, Williamson HG, Won M, Crozier IG, Wells EJ. The course of idiopathic dilated cardiomyopathy in New Zealand. Br Heart J 1987; 57: 521-527.
5. Komajda M, Jais JP, Reeves F, Goldfarb B, Bouhour JB, Juillieres Y, et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J 1990; 11: 824-831.
6. Sugrue DD, Rodeheffer RJ, Codd MB, Ballard DJ, Fuster V, Gersh BJ. The clinical course of idiopathic dilated cardiomyopathy: A population-based study. Ann Intern Med 1992; 117: 117-123.
7. Redfield MM, Gersh BJ, Bailey KR, Rodeheffer RJ. Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74: 737-739.
8. Felker GM, Thompson RE, Hare JM, Hmban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084.
9. Matsumura Y, Takata J, Kitaoka H, Kubo T, Baba Y, Hoshikawa E, et al. Long-term prognosis of dilated cardiomyopathy revisited: An improvement in survival over the past 20 years. Circ J 2006; 70: 376-383.
10. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331: 1564-1575.
11. Miura K, Nakagawa H, Morikawa Y, Sasayama S, Matsumori A, Hasegawa K, et al. Epidemiology of idiopathic cardiomyopathy in Japan: Results from a nationwide survey. Heart 2002; 87: 126-130.
12. Matsumori A, Furukawa Y, Hasegawa K, Sato Y, Nakagawa H, Morikawa Y, et al. Epidemiological and clinical characteristics of cardiomyopathies in Japan: Results from nationwide surveys. Circ J 2002; 66: 323-336.
13. The WHO/ISFC task force on the definition and classification of cardiomyopathies: Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980; 44: 672-673.
14. Research Committee on Idiopathic Cardiomyopathy. Guidelines for the diagnosis of idiopathic cardiomyopathy. In: Annual report of the Research Committee on Idiopathic Cardiomyopathy. Tokyo: Ministry of Health and Welfare, Japan; 1986; 13-5 (in Japanese).
15. Nasermoaddeli A, Miura K, Matsumori A, Soyama Y, Morikawa Y, Kitabatake A, et al. Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: Results from a nationwide study. Heart 2007; 93: 711-715.
16. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
17. Doi YL, Chikamori T, Tanaka J, Yonezawa Y, Poloniecki JD, Ozawa T, et al. Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy. Am J Cardiol 1991; 67: 188-193.
18. Kelly TL, Cremo R, Nielsen C, Shabetai R. Prediction of outcome in late-stage cardiomyopathy. Am Heart J 1990; 119: 1111-1121.